Analystreport

Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) had its price target raised by analysts at Robert W. Baird from $3.00 to $5.00.

Eiger BioPharmaceuticals, Inc.  (EIGR) 
Last eiger biopharmaceuticals, inc. earnings: 3/13 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.eigerbio.com